Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF - Get Free Report)'s share price passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $10.36 and traded as high as $11.19. Ono Pharmaceutical shares last traded at $11.19, with a volume of 13,701 shares changing hands.
Ono Pharmaceutical Price Performance
The stock has a fifty day moving average of $10.26 and a two-hundred day moving average of $11.29. The company has a quick ratio of 2.80, a current ratio of 3.55 and a debt-to-equity ratio of 0.14. The stock has a market cap of $4.42 billion, a price-to-earnings ratio of 9.04 and a beta of 0.73.
Ono Pharmaceutical (OTCMKTS:OPHLF - Get Free Report) last announced its quarterly earnings results on Monday, February 3rd. The company reported $0.21 earnings per share for the quarter. Ono Pharmaceutical had a net margin of 15.15% and a return on equity of 9.10%.
About Ono Pharmaceutical
(
Get Free Report)
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Further Reading
Before you consider Ono Pharmaceutical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ono Pharmaceutical wasn't on the list.
While Ono Pharmaceutical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
